FMOC-GLY-OSU,
113484-74-5,
AK-81198,
SCHEMBL10661146,
CTK8B3881,
DTXSID50460014,
ZINC2539227,
ANW-43361,
MFCD00065651,
(2,5-dioxopyrrolidin-1-yl) 2-(9H-fluoren-9-ylmethoxycarbonylamino)acetate,
AKOS015855268,
RTC-066761,
AS-17790,
AB0020804,
AX8017603,
TC-066761,
FT-0626502,
ST24047274,
V1821,
M-1071,
484F745,
C-25141,
I14-8713,
J-002970,
N-(9H-Fluorene-9-ylmethoxycarbonyl)glycine succinimidyl ester,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-glycine succinimidyl ester,
2,5-dioxopyrrolidin-1-yl 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)acetate,
Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 2,5-dioxo-1-pyrrolidinyl ester,
Glycine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 2,5-dioxo-1-pyrrolidinyl ester,
Glycine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-,2,5-dioxo-1-pyrrolidinyl ester,
C21H18N2O6,
Fmoc-glycine hydroxysuccinimide ester,
Fmoc-Gly-OSu, 96% - 5G 5g,
CID11246395,